Market Cap
75582341120.00
REGN
Regeneron Pharmaceuticals, Inc.
Exchange: nyse
Multiples
- P/E: 17.02
- P/BV: 2.53
- P/TBV: 2.91
Description:
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company listed on the New York Stock Exchange (NYSE) under the ticker symbol REGN. The company is a leader in the discovery, development, and commercialization of innovative therapies for serious diseases. Regeneron's pipeline includes a range of treatments for eye diseases, such as diabetic retinopathy and macular degeneration, as well as medications for other conditions like multiple sclerosis and hypertension. The company has established a strong track record of success, with several of its products receiving FDA approval and generating significant revenue.
Data:
Yields:
Earnings Yield
-0.648290484697
Return on Capital
0.332055086615
CAGR (net income)
7.79%
CAGR Length
3.75
Dividend Rate
